Doctors will be able to purchase drugs administered in their offices directly from selected vendors under a new program announced by the CMS that begins Jan. 1.
The new program will involve only drugs that must be administered in a doctor's office. Of the approximately 440 such drugs covered by Medicare, the program will include 181 that account for 85% of all Medicare spending on physician-injectible drugs.
Doctors in the program will bill Medicare only for administrative services, vendors will bill Medicare for the cost of the drugs and patients will pay any coinsurance or deductibles. Vendors will be selected for participation in the program through competitive contracting. Doctors who don't participate in the program can continue purchasing drugs through drug suppliers and be paid at 106% of the average sales price from Medicare.
Read more at cms.hhs.gov.